Variation in TREK1 gene linked to depression‐resistant phenotype is associated with potentiated neural responses to rewards in humans

The TREK1 gene has been linked to a depression‐resistant phenotype in rodents and antidepressant response in humans, but the neural mechanisms underlying these links are unclear. Because TREK1 is expressed in reward‐related basal ganglia regions, it has been hypothesized that TREK1 genetic variation may be associated with anhedonic symptoms of depression. To investigate whether TREK1 genetic variation influences reward processing, we genotyped healthy individuals (n = 31) who completed a monetary incentive delay task during functional magnetic resonance imaging (fMRI). Three genotypes previously linked to positive antidepressant response were associated with potentiated basal ganglia activity to gains, but did not influence responses to penalties or no change feedback. TREK1 genetic variations did not affect basal ganglia volume, and fMRI group differences were confirmed when accounting for self‐report measures of anhedonia. In addition, the total number of “protective” TREK1 alleles was associated with stronger responses to gains in several other reward‐related regions, including the dorsal anterior cingulate cortex, orbitofrontal cortex, and mesial prefrontal cortex. In control analyses, associations between basal ganglia responses to gains and functional polymorphisms in the dopamine transporter (DAT1) and catechol‐O‐methyltransferase (COMT) genes were also explored. Results revealed that TREK1 and DAT/COMT genotypes were independently related to basal ganglia responses to gains. These findings indicate that TREK1 genotypes are associated with individual differences in reward‐related brain activity. Future studies in depressed samples should evaluate whether variation in neural responses to rewards may contribute to the association between TREK1 and antidepressant response in humans. Hum Brain Mapp, 2010. © 2009 Wiley‐Liss, Inc.

[1]  Brian Knutson,et al.  A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI , 2003, NeuroImage.

[2]  A. Grace,et al.  The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes , 2004, Neuropsychopharmacology.

[3]  Karl J. Friston,et al.  Analysis of fMRI Time-Series Revisited—Again , 1995, NeuroImage.

[4]  Dc Washington.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[5]  A. Hariri,et al.  Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity , 2009, Molecular Psychiatry.

[6]  M. Pangalos,et al.  Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. , 2001, Brain research. Molecular brain research.

[7]  D. Bayliss,et al.  CNS Distribution of Members of the Two-Pore-Domain (KCNK) Potassium Channel Family , 2001, The Journal of Neuroscience.

[8]  D. Charney,et al.  Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. , 2004, The American journal of psychiatry.

[9]  Clinton D Kilts,et al.  The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density , 2005, BMC Genetics.

[10]  Jan Wacker,et al.  The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: Integration of resting EEG, fMRI, and volumetric techniques , 2009, NeuroImage.

[11]  P. Moorjani,et al.  Pharmacogenetic Analysis of Genes Implicated in Rodent Models of Antidepressant Response: Association of TREK1 and Treatment Resistance in the STAR*D Study , 2008, Neuropsychopharmacology.

[12]  Nikos Makris,et al.  Automatically parcellating the human cerebral cortex. , 2004, Cerebral cortex.

[13]  X Li,et al.  Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. , 1992, Genomics.

[14]  M. Delgado,et al.  Reward‐Related Responses in the Human Striatum , 2007, Annals of the New York Academy of Sciences.

[15]  R. Hen,et al.  TREKing toward new antidepressants , 2006, Nature Neuroscience.

[16]  R Turner,et al.  Optimized EPI for fMRI studies of the orbitofrontal cortex , 2003, NeuroImage.

[17]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[18]  R A McCormick,et al.  Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. , 1995, Journal of abnormal psychology.

[19]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[20]  Jeffrey L. Birk,et al.  Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. , 2009, The American journal of psychiatry.

[21]  L. J. Chapman,et al.  The measurement of handedness , 1987, Brain and Cognition.

[22]  E. Nestler,et al.  Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action , 2006, Nature Neuroscience.

[23]  A. Holmes,et al.  Dissociation of neural regions associated with anticipatory versus consummatory phases of incentive processing. , 2007, Psychophysiology.

[24]  G. Hervieu,et al.  Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS , 2001, Neuroscience.

[25]  D. Watson,et al.  Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.

[26]  R. de Graaf,et al.  Determinants of poor 1‐year outcome of DSM‐III‐R major depression in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS) , 2001, Acta psychiatrica Scandinavica.

[27]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[28]  Daniel G. Dillon,et al.  Individual differences in reinforcement learning: Behavioral, electrophysiological, and neuroimaging correlates , 2008, NeuroImage.

[29]  S. Shankman,et al.  Behavioral activation system deficits predict the six-month course of depression. , 2006, Journal of affective disorders.

[30]  W. Drevets,et al.  Discovering Endophenotypes for Major Depression , 2004, Neuropsychopharmacology.

[31]  S. Tsai.  Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1. , 2008, Medical hypotheses.

[32]  Jeffrey L. Birk,et al.  Reduced Caudate and Nucleus Accumbens Response to Rewards in Unmedicated Subjects with Major Depressive Disorder , 2009 .

[33]  P. Holland,et al.  Amygdala–frontal interactions and reward expectancy , 2004, Current Opinion in Neurobiology.

[34]  J. Gläscher,et al.  Gene–gene interaction associated with neural reward sensitivity , 2007, Proceedings of the National Academy of Sciences.

[35]  Timothy Edward John Behrens,et al.  Contrasting roles for cingulate and orbitofrontal cortex in decisions and social behaviour , 2007, Trends in Cognitive Sciences.

[36]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[37]  E. Honoré,et al.  The neuronal background K2P channels: focus on TREK1 , 2007, Nature Reviews Neuroscience.

[38]  John C. Markowitz,et al.  Treatment and Prevention of Depression , 2002, Psychological science in the public interest : a journal of the American Psychological Society.

[39]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[40]  R. Moos,et al.  Symptom-based predictors of a 10-year chronic course of treated depression. , 1999, The Journal of nervous and mental disease.

[41]  Thomas E. Nichols,et al.  Optimization of experimental design in fMRI: a general framework using a genetic algorithm , 2003, NeuroImage.

[42]  Brian Knutson,et al.  Anticipation of Increasing Monetary Reward Selectively Recruits Nucleus Accumbens , 2001, The Journal of Neuroscience.

[43]  A. Tversky,et al.  Prospect theory: an analysis of decision under risk — Source link , 2007 .

[44]  Xiao-Li Meng,et al.  Comparing correlated correlation coefficients , 1992 .

[45]  Paolo Cassano,et al.  Depression and public health: an overview. , 2002, Journal of psychosomatic research.

[46]  G. Debonnel,et al.  Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype , 2006, Nature Neuroscience.

[47]  J. Lancaster,et al.  Using the talairach atlas with the MNI template , 2001, NeuroImage.

[48]  B. Lipska,et al.  Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function , 2003, Neuroscience.

[49]  J. O'Doherty,et al.  Reward representations and reward-related learning in the human brain: insights from neuroimaging , 2004, Current Opinion in Neurobiology.

[50]  Nikos Makris,et al.  Association of a polymorphism near CREB1 with differential aversion processing in the insula of healthy participants. , 2008, Archives of general psychiatry.

[51]  B. Kolachana,et al.  Variation in dopamine genes influences responsivity of the human reward system , 2009, Proceedings of the National Academy of Sciences.

[52]  R. Weinshilboum,et al.  Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. , 1999, Annual review of pharmacology and toxicology.

[53]  S. Haber,et al.  Immunocytochemical localization of the dopamine transporter in human brain , 1999, The Journal of comparative neurology.